Background: Atopic dermatitis is a chronically relapsing inflammatory skin disease. Animal models induced by relevant allergens play a very important role in the elucidation of the disease. The patients with atopic der-matitis are highly sensitized with mite allergens such as Dermatophagoides farinae (Df). Therefore, in the pre-sent study, we tried to develop a novel model for atopic dermatitis by repeated application with Df extract oint-ment. Methods: Df extract ointment was repeatedly applied to the back of NCNga mice together with barrier disrup-tion. Atopic dermatitis-like skin lesions were evaluated by dermatitis scores, skin histology and immunological parameters. The effect of corticosteroid and calcineurin inhibitor was also examin...
Atopic dermatitis (AD) is a chronic inflammatory disease, characterized by eczematous lesion (skin i...
Atopic eczema (AE) is a chronic relapsing inflammatory skin disorder with increasing prevalence in W...
BACKGROUND: Several studies have demonstrated that allergen-specific immunotherapy (SIT) can be ...
ABSTRACTBackgroundAtopic dermatitis is a chronically relapsing inflammatory skin disease. Animal mod...
ABSTRACTBackgroundAtopic dermatitis is a chronically relapsing inflammatory skin disease. Animal mod...
Background: Atopic dermatitis is a chronic or chronically relapsing, pruritic inflammatory skin dise...
ABSTRACTBackgroundAtopic dermatitis is a chronic or chronically relapsing, pruritic inflammatory ski...
Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease, and the pathogenesis is...
Background: The purpose of this study is to conduct a histopathological research of the conjunctival...
AbstractBackgroundThe increasing incidence and prevalence of atopic dermatitis (AD) demands new ther...
Atopic dermatitis (AD) is a common, chronic inflammatory skin disease characterized by impaired barr...
We evaluated the anti-atopic dermatitis (AD) effect of Atofreellage (AF), a herbal formula composed ...
Atopic dermatitis (AD) is a chronic inflammatory disease, characterized by eczematous lesion (skin i...
We evaluated the anti-atopic dermatitis (AD) effect of Atofreellage (AF), a herbal formula composed ...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Atopic dermatitis (AD) is a chronic inflammatory disease, characterized by eczematous lesion (skin i...
Atopic eczema (AE) is a chronic relapsing inflammatory skin disorder with increasing prevalence in W...
BACKGROUND: Several studies have demonstrated that allergen-specific immunotherapy (SIT) can be ...
ABSTRACTBackgroundAtopic dermatitis is a chronically relapsing inflammatory skin disease. Animal mod...
ABSTRACTBackgroundAtopic dermatitis is a chronically relapsing inflammatory skin disease. Animal mod...
Background: Atopic dermatitis is a chronic or chronically relapsing, pruritic inflammatory skin dise...
ABSTRACTBackgroundAtopic dermatitis is a chronic or chronically relapsing, pruritic inflammatory ski...
Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease, and the pathogenesis is...
Background: The purpose of this study is to conduct a histopathological research of the conjunctival...
AbstractBackgroundThe increasing incidence and prevalence of atopic dermatitis (AD) demands new ther...
Atopic dermatitis (AD) is a common, chronic inflammatory skin disease characterized by impaired barr...
We evaluated the anti-atopic dermatitis (AD) effect of Atofreellage (AF), a herbal formula composed ...
Atopic dermatitis (AD) is a chronic inflammatory disease, characterized by eczematous lesion (skin i...
We evaluated the anti-atopic dermatitis (AD) effect of Atofreellage (AF), a herbal formula composed ...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Atopic dermatitis (AD) is a chronic inflammatory disease, characterized by eczematous lesion (skin i...
Atopic eczema (AE) is a chronic relapsing inflammatory skin disorder with increasing prevalence in W...
BACKGROUND: Several studies have demonstrated that allergen-specific immunotherapy (SIT) can be ...